Many with atherosclerotic CVD not meeting LDL-C goals

(HealthDay)—A high proportion of patients with atherosclerotic cardiovascular disease (ASCVD) do not achieve recommended low-density lipoprotein cholesterol (LDL-C) goals, according to a study presented at the annual meeting of the American Heart Association, held from Nov. 16 to 18 in Philadelphia. Joseph Allen, from the American College of Cardiology in Washington, D.C., and colleagues examined LDL-C goal attainment (LDL-C

Continue reading »

A new model to estimate lifetime risk of atherosclerotic cardiovascular disease

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality and also contributes to huge health care expenditures in China. Therefore, accurate and early identification of high-risk individuals is important for CVD prevention. The China-PAR (Prediction for atherosclerotic CVD (ASCVD) Risk in China) project generated equations with excellent capacity to predict lifetime risk for ASCVD by incorporating four large […]

Continue reading »